OFIXOrthofix Medical Inc.
Price
-37%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
Quality strong, nothing alarming, growth steady, the market against it.
Charts
As reported to the SEC, without any scoring.
Orthofix Medical Inc. (OFIX) reported revenue of $211M in Q2 2026 (quarter ended Jun 30, 2026), up 3.8% from the same quarter a year earlier. That came with a gross margin of 71% and net loss of $16M. For the full year FY2025, revenue was $822M (+2.9% year on year) and net income −$92M. The next results filing is expected around Nov 3, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 5, 2026Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress.Earnings release · press release
- Jun 11, 2026Approval of Amendment No. 5 to the Second Amended and Restated Stock Purchase Plan On June 10, 2026, Orthofix Medical Inc. (the " Company ") held its 2026 Annual Meeting of Shareholders (the " Annual Meeting ")Director or officer change · Form 8-K
- May 5, 2026Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.